Plasma metabolomic profiling suggests early indications for predisposition to latent insulin resistance in children conceived by ICSI

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Gkourogianni, Alexandra ^a   Kosteria, Ioanna ^a   Telonis, Aristeidis G ^b,e   Margeli, Alexandra ^c   Mantzou, Emilia ^d   Konsta, Maria ^a   Loutradis, Dimitrios ^a   Mastorakos, George ^a   Papassotiriou, Ioannis ^c   Klapa, Maria I ^b   Kanaka Gantenbein, Christina ^a   Chrousos, George P ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b INSTITUTE OF CHEMICAL ENGINEERING SCIENCES   (Greece)

^c AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^d Evgenidion Hospital   (Greece)

^e UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; LIOTHYRONINE; UNCLASSIFIED DRUG; UREA; YKL 40 PROTEIN;

ARTICLE; BLOOD ANALYSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INSULIN RESISTANCE; INTRACYTOPLASMIC SPERM INJECTION; MALE; MASS FRAGMENTOGRAPHY; METABOLIC SYNDROME X; METABOLOMICS; OBESITY; PREPUBERTY; ADULT; BLOOD; DISEASE PREDISPOSITION; METABOLOME; MIDDLE AGED; PHYSIOLOGY; PRESCHOOL CHILD; PROCEDURES;

ADULT; CHILD; CHILD, PRESCHOOL; DISEASE SUSCEPTIBILITY; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; INSULIN RESISTANCE; MALE; METABOLOME; METABOLOMICS; MIDDLE AGED; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 84899654569     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094001     Document Type: Article

References (48)

1. Ferraretti AP, Goossens V, de Mouzon J, Bhattacharya S, Castilla JA, et al. (2012) Assisted reproductive technology in Europe, 2008: results generated from European registers by ESHRE. Hum Reprod 27: 2571-2584.
2. Palermo G, Joris H, Devroey P, Van Steirteghem AC (1992) Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet 340: 17-18.
3. Van Steirteghem A, Devroey P, Liebaers I (2002) Intracytoplasmic sperm injection. Mol Cell Endocrinol 186: 199-203.
4. Maher ER (2005) Imprinting and assisted reproductive technology. Hum Mol Genet 14 Spec No 1: R133-138.
5. Kanaka-Gantenbein C, Sakka S, Chrousos GP (2010) Assisted reproduction and its neuroendocrine impact on the offspring. Prog Brain Res 182: 161-174.
6. Wen J, Jiang J, Ding C, Dai J, Liu Y, et al. (2012) Birth defects in children conceived by in vitro fertilization and intracytoplasmic sperm injection: a metaanalysis. Fertil Steril 97: 1331-1337 e1331-1334.
7. Nyboe Andersen A, Carlsen E, Loft A (2008) Trends in the use of intracytoplasmatic sperm injection marked variability between countries. Hum Reprod Update 14: 593-604.
8. Grace KS, Sinclair KD (2009) Assisted reproductive technology, epigenetics, and long-term health: a developmental time bomb still ticking. Semin Reprod Med 27: 409-416.
9. Kanaka-Gantenbein C, Mastorakos G, Chrousos GP (2003) Endocrine-related causes and consequences of intrauterine growth retardation. Ann N Y Acad Sci 997: 150-157.
10. Saenger P, Czernichow P, Hughes I, Reiter EO (2007) Small for gestational age: short stature and beyond. Endocr Rev 28: 219-251.
11. Gluckman PD, Hanson MA, Cooper C, Thornburg KL (2008) Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 359: 61-73.
12. McDonald SD, Han Z, Mulla S, Murphy KE, Beyene J, et al. (2009) Preterm birth and low birth weight among in vitro fertilization singletons: a systematic review and meta-analyses. Eur J Obstet Gynecol Reprod Biol 146: 138-148.
13. Sakka SD, Loutradis D, Kanaka-Gantenbein C, Margeli A, Papastamataki M, et al. (2010) Absence of insulin resistance and low-grade inflammation despite early metabolic syndrome manifestations in children born after in vitro fertilization. Fertil Steril 94: 1693-1699.
14. Ceelen M, van Weissenbruch MM, Vermeiden JP, van Leeuwen FE, Delemarre-van de Waal HA (2008) Cardiometabolic differences in children born after in vitro fertilization: follow-up study. J Clin Endocrinol Metab 93: 1682-1688.
15. Chrousos GP (2000) The role of stress and the hypothalamic-pituitary- adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes. Int J Obes Relat Metab Disord 24 Suppl 2: S50-55.
16. Laprise SL (2009) Implications of epigenetics and genomic imprinting in assisted reproductive technologies. Mol Reprod Dev 76: 1006-1018.
17. Youngson NA, Morris MJ (2013) What obesity research tells us about epigenetic mechanisms. Philos Trans R Soc Lond B Biol Sci 368: 20110337.
18. Vidal M (2009) A unifying view of 21st century systems biology. FEBS Lett 583: 3891-3894.
19. Patti GJ, Yanes O, Siuzdak G (2012) Innovation: Metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol 13: 263-269.
20. Nicholson G, Rantalainen M, Maher AD, Li JV, Malmodin D, et al. (2011) Human metabolic profiles are stably controlled by genetic and environmental variation. Mol Syst Biol 7: 525.
21. Mittelstrass K, Ried JS, Yu Z, Krumsiek J, Gieger C, et al. (2011) Discovery of sexual dimorphisms in metabolic and genetic biomarkers. PLoS Genet 7: e1002215.
22. Ucar A, Saka N, Bas F, Bundak R, Gunoz H, et al. (2012) Precocious adrenarche in children born appropriate for gestational age: is there a difference between genders? Eur J Pediatr 171: 1661-1666.
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
24. Kanani HH, Klapa MI (2007) Data correction strategy for metabolomics analysis using gas chromatography-mass spectrometry. Metab Eng 9: 39-51.
25. Spagou K, Theodoridis G, Wilson I, Raikos N, Greaves P, et al. (2011) A GCMS metabolic profiling study of plasma samples from mice on low-and high-fat diets. J Chromatogr B Analyt Technol Biomed Life Sci 879: 1467-1475.
26. Saeed AI, Bhagabati NK, Braisted JC, Liang W, Sharov V, et al. (2006) TM4 microarray software suite. Methods Enzymol 411: 134-193.
27. Ortega FJ, Jilkova ZM, Moreno-Navarrete JM, Pavelka S, Rodriguez-Hermosa JI, et al. (2012) Type I iodothyronine 59-deiodinase mRNA and activity is increased in adipose tissue of obese subjects. Int J Obes (Lond) 36: 320-324.
28. Mitrou P, Raptis SA, Dimitriadis G (2010) Insulin action in hyperthyroidism: a focus on muscle and adipose tissue Endocr Rev 31: 663-679.
29. Brenta G (2011) Why can insulin resistance be a natural consequence of thyroid dysfunction? J Thyroid Res 2011: 152850.
30. Sakka SD, Malamitsi-Puchner A, Loutradis D, Chrousos GP, Kanaka-Gantenbein C (2009) Euthyroid hyperthyrotropinemia in children born after in vitro fertilization. J Clin Endocrinol Metab 94: 1338-1341.
31. Barber T, Vina JR, Vina J, Cabo J (1985) Decreased urea synthesis in cafeteriadiet-induced obesity in the rat. Biochem J 230: 675-681.
32. Herrero MC, Remesar X, Arola L, Blade C (1999) Ammonium uptake and urea production in hepatocytes from lean and obese Zucker rats. Mol Cell Biochem 200: 163-167.
33. Belva F, Painter RC, Schiettecatte J, Bonduelle M, Roelants M, et al. (2013) Gender-specific alterations in salivary cortisol levels in pubertal intracytoplasmic sperm injection offspring. Horm Res Paediatr 80:350-355.
34. Kaseva N, Wehkalampi K, Pyhä lä R, Moltchanova E, Feldt K, et al. (2014) Blunted hypothalamic-pituitary-adrenal axis and insulin response to psychosocial stress in young adults born preterm at very low birth weight. Clin Endocrinol (Oxf) 80:101-106.
35. Kajantie E, Feldt K, Rä ikkönen K, Phillips DI, Osmond C, et al. (2007) Body size at birth predicts hypothalamic-pituitary-adrenal axis response to psychosocial stress at age 60 to 70 years. J Clin Endocrinol Metab 92:4094-4100.
36. Kyrgios I, Galli-Tsinopoulou A, Stylianou C, Papakonstantinou E, Arvanitidou M, et al. (2012) Elevated circulating levels of the serum acute-phase protein YKL-40 (chitinase 3-like protein 1) are a marker of obesity and insulin resistance in prepubertal children. Metabolism 61:562-568.
37. Rathcke CN, Thomsen SB, Linneberg A, Vestergaard H (2012) Variations of CHI3L1, levels of the encoded glycoprotein YKL-40 and prediction of fatal and non-fatal ischemic stroke. PLoS One 7(8):e43498.
38. Lin CH, Li HY, Jiang YD, Chang TJ, Chuang LM (2013) Plasma YKL-40 predicts 10-year cardiovascular and all-cause mortality in individuals with type 2 diabetes.Clin Endocrinol (Oxf). 79(2):185-191.
39. Cori CF (1981) The glucose-lactic acid cycle and gluconeogenesis. Curr Top Cell Regul 18: 377-387.
40. Zawadzki JK, Wolfe RR, Mott DM, Lillioja S, Howard BV, et al. (1988) Increased rate of Cori cycle in obese subjects with NIDDM and effect of weight reduction. Diabetes 37: 154-159.
41. Sabin MA, De Hora M, Holly JM, Hunt LP, Ford AL, et al. (2007) Fasting nonesterified fatty acid profiles in childhood and their relationship with adiposity, insulin sensitivity, and lipid levels. Pediatrics 120: e1426-1433.
42. Schaffer JE (2003) Lipotoxicity: when tissues overeat. Curr Opin Lipidol 14: 281-287.
43. Le Stunff C, Bougneres PF (1992) Glycerol production and utilization during the early phase of human obesity. Diabetes 41: 444-450.
44. Traber MG (2007) Vitamin E regulatory mechanisms. Annu Rev Nutr 27: 347-362.
45. Bieri JG, Evarts RP (1975) Effect of plasma lipid levels and obesity on tissue stores of alpha-tocopherol. Proc Soc Exp Biol Med 149: 500-502.
46. Manolescu B, Atanasiu V, Cercasov C, Stoian I, Oprea E, et al. (2008) So many options but one choice: the human body prefers alpha-tocopherol. A matter of stereochemistry. J Med Life 1: 376-382.
47. Muoio DM, Newgard CB (2006) Obesity-related derangements in metabolic regulation. Annu Rev Biochem 75: 367-401.
48. Sakka SD, Margeli A, Loutradis D, Chrousos GP, Papassotiriou I, et al. (2013) Gender dimorphic increase in RBP-4 and NGAL in children born after IVF: an epigenetic phenomenon? Eur J Clin Invest 43: 439-448.